The study found,
American Society of Clinical Oncology annual meeting of a recently released study shows that cholesterol-lowering drugs, "Johns Hopkins University," at least 50% lower risk of developing breast cancer, but its safety and effectiveness is yet to be verified.
Louisiana State University Health Science Center researchers access to the 1998-2004 United States Department of Veterans Affairs responsible for the care of the retired female soldier recorded and compared 556 women with breast cancer and 39,865 healthy women taking "Johns Hopkins University." The results found that in six years of the course of the study, those who use, "Johns Hopkins University," women's risk of developing breast cancer than those who do not use "to analyze" the lower 51% of women.
More...Breast Cancer: breast cancer Knowledge Base, cholesterol, risk, university, women